Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells

C.W. Feltkamp, Mariet; L. Smits, Henk; Vierboom, Michel; Minnaar, René; M. de Jongh, B.; W. Drijfhout, Jan; ter Schegget, Jan; J.M. Melief, Cornelis; Martin Kast, W.

doi:10.1002/eji.1830230929

Public

Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells

Published in European Journal of Immunology • Sep 1, 1993

Authors:

Mariet C.W. Feltkamp

Henk L. Smits

Michel Vierboom

Abstract

Cytotoxic T lymphocyte (CTL) peptide epitopes can be used for immunization of mice against lethal virus infection. To study whether this approach can be successful against virus-induced tumors we generated a B6 (H-2b) tumorigenic cell line transformed by human papillomavirus (HPV). This virus is det...

Subject

Epitope

CTL*

Cytotoxic T cell

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!